HomeERMA • STO
add
Enorama Pharma AB
Previous close
kr 0.33
Day range
kr 0.33 - kr 0.35
Year range
kr 0.21 - kr 3.58
Market cap
23.95M SEK
Avg Volume
78.88K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.75M | -33.70% |
Operating expense | 14.94M | -40.51% |
Net income | -20.57M | 6.51% |
Net profit margin | -1.17K | -41.01% |
Earnings per share | — | — |
EBITDA | -18.38M | 30.31% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.04M | 45.66% |
Total assets | 8.26M | -48.02% |
Total liabilities | 31.71M | 291.95% |
Total equity | -23.45M | — |
Shares outstanding | 74.59M | — |
Price to book | -1.05 | — |
Return on assets | -443.43% | — |
Return on capital | 328.77% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -20.57M | 6.51% |
Cash from operations | -14.79M | -347.76% |
Cash from investing | — | — |
Cash from financing | 9.50M | 3,058.26% |
Net change in cash | -3.53M | 53.17% |
Free cash flow | 2.22M | 113.67% |
About
Founded
2006
Website
Employees
5
